User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy

  1. Ling C.Clifton, Humm John, Larson Steven, Amols Howard, Fuks Zvi, Leibel Steven, Koutcher Jason A, Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality, 10.1016/s0360-3016(00)00467-3
  2. Bentzen Søren M, Theragnostic imaging for radiation oncology: dose-painting by numbers, 10.1016/s1470-2045(05)01737-7
  3. Aupérin Anne, Le Péchoux Cecile, Rolland Estelle, Curran Walter J., Furuse Kiyoyuki, Fournel Pierre, Belderbos Jose, Clamon Gerald, Ulutin Hakki Cuneyt, Paulus Rebecca, Yamanaka Takeharu, Bozonnat Marie-Cecile, Uitterhoeve Apollonia, Wang Xiaofei, Stewart Lesley, Arriagada Rodrigo, Burdett Sarah, Pignon Jean-Pierre, Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer, 10.1200/jco.2009.26.2543
  4. Machtay Mitchell, Paulus Rebecca, Moughan Jennifer, Komaki Ritsuko, Bradley J effrey, Choy Hak, Albain Kathy, Movsas Benjamin, Sause William T., Curran Walter J., Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma, 10.1097/jto.0b013e3182429682
  5. Bradley Jeffrey D, Paulus Rebecca, Komaki Ritsuko, Masters Gregory, Blumenschein George, Schild Steven, Bogart Jeffrey, Hu Chen, Forster Kenneth, Magliocco Anthony, Kavadi Vivek, Garces Yolanda I, Narayan Samir, Iyengar Puneeth, Robinson Cliff, Wynn Raymond B, Koprowski Christopher, Meng Joanne, Beitler Jonathan, Gaur Rakesh, Curran Walter, Choy Hak, Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study, 10.1016/s1470-2045(14)71207-0
  6. Wanet Marie, Lee John Aldo, Weynand Birgit, De Bast Marc, Poncelet Alain, Lacroix Valérie, Coche Emmanuel, Grégoire Vincent, Geets Xavier, Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: A comparison with threshold-based approaches, CT and surgical specimens, 10.1016/j.radonc.2010.10.006
  7. Aerts Hugo J.W.L., van Baardwijk Angela A.W., Petit Steven F., Offermann Claudia, Loon Judith van, Houben Ruud, Dingemans Anne-Marie C., Wanders Rinus, Boersma Liesbeth, Borger Jacques, Bootsma Gerben, Geraedts Wiel, Pitz Cordula, Simons Jean, Wouters Bradly G., Oellers Michel, Lambin Philippe, Bosmans Geert, Dekker Andre L.A.J., Ruysscher Dirk De, Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan, 10.1016/j.radonc.2009.03.006
  8. Calais J., Thureau S., Dubray B., Modzelewski R., Thiberville L., Gardin I., Vera P., Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non-Small Cell Lung Cancer, 10.2967/jnumed.114.144253
  9. Berwouts Dieter, Olteanu Luiza A.M., Duprez Fréderic, Vercauteren Tom, De Gersem Werner, De Neve Wilfried, Van de Wiele Christophe, Madani Indira, Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial, 10.1016/j.radonc.2013.04.002
  10. van Elmpt Wouter, De Ruysscher Dirk, van der Salm Anke, Lakeman Annemarie, van der Stoep Judith, Emans Daisy, Damen Eugène, Öllers Michel, Sonke Jan-Jakob, Belderbos José, The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer, 10.1016/j.radonc.2012.03.005
  11. Piert M, J Nucl Med, 46, 106 (2005)
  12. Gray L. H., Conger A. D., Ebert M., Hornsey S., Scott O. C. A., The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy, 10.1259/0007-1285-26-312-638
  13. Popple Richard A., Ove Roger, Shen Sui, Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation, 10.1016/s0360-3016(02)03007-9
  14. Thorwarth Daniela, Eschmann Susanne-Martina, Paulsen Frank, Alber Markus, Hypoxia Dose Painting by Numbers: A Planning Study, 10.1016/j.ijrobp.2006.11.061
  15. Lohith T. G., Kudo T., Demura Y., Umeda Y., Kiyono Y., Fujibayashi Y., Okazawa H., Pathophysiologic Correlation Between 62Cu-ATSM and 18F-FDG in Lung Cancer, 10.2967/jnumed.109.069021
  16. Bollineni V. R., Kerner G. S. M. A., Pruim J., Steenbakkers R. J. H. M., Wiegman E. M., Koole M. J. B., de Groot E. H., Willemsen A. T. M., Luurtsema G., Widder J., Groen H. J. M., Langendijk J. A., PET Imaging of Tumor Hypoxia Using 18F-Fluoroazomycin Arabinoside in Stage III-IV Non-Small Cell Lung Cancer Patients, 10.2967/jnumed.112.115014
  17. Zegers C. M. L., van Elmpt W., Reymen B., Even A. J. G., Troost E. G. C., Ollers M. C., Hoebers F. J. P., Houben R. M. A., Eriksson J., Windhorst A. D., Mottaghy F. M., De Ruysscher D., Lambin P., In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging, 10.1158/1078-0432.ccr-14-1524
  18. van Elmpt Wouter, Zegers Catharina M. L., Reymen Bart, Even Aniek J. G., Dingemans Anne-Marie C., Oellers Michel, Wildberger Joachim E., Mottaghy Felix M., Das Marco, Troost Esther G. C., Lambin Philippe, Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion, 10.1007/s00259-015-3169-4
  19. Di Perri Dario, Lee John A., Bol Anne, Hanin François-Xavier, Janssens Guillaume, Labar Daniel, Robert Annie, Sterpin Edmond, Geets Xavier, Evolution of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside PET uptake distributions in lung tumours during radiation therapy, 10.1080/0284186x.2017.1287943
  20. Goossens Samuel, Senny Frédéric, Lee John Aldo, Janssens Guillaume, Geets Xavier, Assessment of tumor motion reproducibility with audio-visual coaching through successive 4D CT sessions, 10.1120/jacmp.v15i1.4332
  21. Servagi-Vernat Stéphanie, Differding Sarah, Hanin Francois-Xavier, Labar Daniel, Bol Anne, Lee John A., Grégoire Vincent, A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy, 10.1007/s00259-014-2730-x
  22. Janssens Guillaume, Jacques Laurent, Orban de Xivry Jonathan, Geets Xavier, Macq Benoit, Diffeomorphic Registration of Images with Variable Contrast Enhancement, 10.1155/2011/891585
  23. Wanet Marie, Sterpin Edmond, Janssens Guillaume, Delor Antoine, Lee John Aldo, Geets Xavier, Validation of the mid-position strategy for lung tumors in helical TomoTherapy, 10.1016/j.radonc.2013.10.025
  24. Wolthaus J. W. H., Sonke J.-J., van Herk M., Damen E. M. F., Reconstruction of a time-averaged midposition CT scan for radiotherapy planning of lung cancer patients using deformable registrationa) : Midposition CT reconstruction using deformable registration, 10.1118/1.2966347
  25. Kruis Matthijs F., van de Kamer Jeroen B., Houweling Antonetta C., Sonke Jan-Jakob, Belderbos José S.A., van Herk Marcel, PET Motion Compensation for Radiation Therapy Using a CT-Based Mid-Position Motion Model: Methodology and Clinical Evaluation, 10.1016/j.ijrobp.2013.06.007
  26. Thureau S., Chaumet-Riffaud P., Modzelewski R., Fernandez P., Tessonnier L., Vervueren L., Cachin F., Berriolo-Riedinger A., Olivier P., Kolesnikov-Gauthier H., Blagosklonov O., Bridji B., Devillers A., Collombier L., Courbon F., Gremillet E., Houzard C., Caignon J. M., Roux J., Aide N., Brenot-Rossi I., Doyeux K., Dubray B., Vera P., Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3'-Deoxy-3'-18F-Fluorothymidine PET Images in Lung Cancer, 10.2967/jnumed.112.118083
  27. Aerts Hugo J.W.L., Bosmans Geert, van Baardwijk Angela A.W., Dekker Andre L.A.J., Oellers Michel C., Lambin Philippe, De Ruysscher Dirk, Stability of 18F-Deoxyglucose Uptake Locations Within Tumor During Radiotherapy for NSCLC: A Prospective Study, 10.1016/j.ijrobp.2007.11.049
  28. Dehdashti Farrokh, Mintun Mark A., Lewis Jason S., Bradley Jeffrey, Govindan Ramaswamy, Laforest Richard, Welch Michael J., Siegel Barry A., In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM, 10.1007/s00259-003-1130-4
  29. Kinoshita Tomonari, Fujii Hirofumi, Hayashi Yuichiro, Kamiyama Ikuo, Ohtsuka Takashi, Asamura Hisao, Prognostic significance of hypoxic PET using 18 F-FAZA and 62 Cu-ATSM in non-small-cell lung cancer, 10.1016/j.lungcan.2015.11.020
  30. Gagel Bernd, Reinartz Patrick, Demirel Cengiz, Kaiser Hans J, Zimny Michael, Piroth Marc, Pinkawa Michael, Stanzel Sven, Asadpour Branka, Hamacher Kurt, Coenen Heinz H, Buell Ulrich, Eble Michael J, [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study, 10.1186/1471-2407-6-51
  31. Cherk MH, J Nucl Med, 47, 1921 (2006)
  32. Vera Pierre, Bohn Pierre, Edet-Sanson Agathe, Salles Alice, Hapdey Sebastien, Gardin Isabelle, Ménard Jean-François, Modzelewski Romain, Thiberville Luc, Dubray Bernard, Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT), and hypoxia with 18fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study, 10.1016/j.radonc.2010.10.011
  33. Sachpekidis C, Am J Nucl Med Mol Imaging, 5, 127 (2015)
  34. Carlin S., Zhang H., Reese M., Ramos N. N., Chen Q., Ricketts S.-A., A Comparison of the Imaging Characteristics and Microregional Distribution of 4 Hypoxia PET Tracers, 10.2967/jnumed.113.126615
  35. Zegers Catharina M.L., van Elmpt Wouter, Wierts Roel, Reymen Bart, Sharifi Hoda, Öllers Michel C., Hoebers Frank, Troost Esther G.C., Wanders Rinus, van Baardwijk Angela, Brans Boudewijn, Eriksson Jonas, Windhorst Bert, Mottaghy Felix M., De Ruysscher Dirk, Lambin Philippe, Hypoxia imaging with [18F]HX4 PET in NSCLC patients: Defining optimal imaging parameters, 10.1016/j.radonc.2013.08.031
  36. Liu Chi, Pierce II Larry A, Alessio Adam M, Kinahan Paul E, The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging, 10.1088/0031-9155/54/24/007
  37. Neicu Toni, Berbeco Ross, Wolfgang John, Jiang Steve B, Synchronized moving aperture radiation therapy (SMART): improvement of breathing pattern reproducibility using respiratory coaching, 10.1088/0031-9155/51/3/010
  38. Christian Nicolas, Deheneffe Stéphanie, Bol Anne, De Bast Marc, Labar Daniel, Lee John A., Grégoire Vincent, Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumor models, 10.1016/j.radonc.2010.02.020
  39. Ljungkvist Anna S.E, Bussink Johan, Rijken Paulus F.J.W, Kaanders Johannes H.A.M, van der Kogel Albert J, Denekamp Juliana, Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas, 10.1016/s0360-3016(02)02938-3
  40. Trani D., Yaromina A., Dubois L., Granzier M., Peeters S. G. J. A., Biemans R., Nalbantov G., Lieuwes N., Reniers B., Troost E. E. G. C., Verhaegen F., Lambin P., Preclinical Assessment of Efficacy of Radiation Dose Painting Based on Intratumoral FDG-PET Uptake, 10.1158/1078-0432.ccr-15-0290
Bibliographic reference Di Perri, Dario ; Lee, John Aldo ; Bol, Anne ; Hanin, François-Xavier ; Janssens, Guillaume ; et. al. Correlation analysis of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside uptake distributions in lung tumours during radiation therapy. In: Acta Oncologica, Vol. 56, p. 1181-1188 (2017)
Permanent URL